Zobrazeno 1 - 10
of 704
pro vyhledávání: '"Francesco Bertoni"'
Autor:
Filippo Spriano, Giulio Sartori, Jacopo Sgrignani, Laura Barnabei, Alberto J. Arribas, Matilde Guala, Ana Maria Carrasco Del Amor, Meagan R. Tomasso, Chiara Tarantelli, Luciano Cascione, Gaetanina Golino, Maria E Riveiro, Roberta Bortolozzi, Antonio Lupia, Francesco Paduano, Samuel Huguet, Keyvan Rezai, Andrea Rinaldi, Francesco Margheriti, Pedro Ventura, Greta Guarda, Giosuè Costa, Roberta Rocca, Alberto Furlan, Luuk M. Verdonk, Paolo Innocenti, Nathaniel I. Martin, Giampietro Viola, Christoph Driessen, Emanuele Zucca, Anastasios Stathis, Digvijay Gahtory, Maurits van den Nieuwboer, Beat Bornhauser, Stefano Alcaro, Francesco Trapasso, Susana Cristobal, Shae B. Padrick, Natalina Pazzi, Franco Cavalli, Andrea Cavalli, Eugenio Gaudio, Francesco Bertoni
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Hematological cancers are among the most common cancers in adults and children. Despite significant improvements in therapies, many patients still succumb to the disease. Therefore, novel therapies are needed. The Wiskott-Aldrich syndrome protein (WA
Externí odkaz:
https://doaj.org/article/1fcdabe916834d5e99ed8d590cb92b6a
Autor:
Chiara Tarantelli, David Wald, Nicolas Munz, Filippo Spriano, Alessio Bruscaggin, Eleonora Cannas, Luciano Cascione, Eugenio Gaudio, Alberto J. Arribas, Shivaprasad Manjappa, Gaetanina Golino, Lorenzo Scalise, Maria Teresa Cacciapuoti, Emanuele Zucca, Anastasios Stathis, Giorgio Inghirami, Patrick H. van Berkel, Davide Rossi, Paolo F. Caimi, Francesca Zammarchi, Francesco Bertoni
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Antibody-drug conjugates (ADCs) represent one of the most successful therapeutic approaches introduced in clinical practice in the last few years. Loncastuximab tesirine (ADCT-402) is a CD19 targeting ADC, in which the antibody is conjugated through
Externí odkaz:
https://doaj.org/article/0ddadfd5eefa4ca48941dd698807b5c9
Autor:
Anastasios Stathis, Maria Cristina Pirosa, Lorella Orsucci, Pierre Feugier, Monica Tani, Hervé Ghesquières, Gerardo Musuraca, Francesca Gaia Rossi, Francesco Merli, Romain Guièze, Emmanuel Gyan, Guido Gini, Dario Marino, Remy Gressin, Franck Morschhauser, Federica Cavallo, Francesca Palombi, Annarita Conconi, Benoît Tessoulin, Hervé Tilly, Manuela Zanni, Maria Giuseppina Cabras, Enrico Capochiani, Catello Califano, Melania Celli, Alessandro Pulsoni, Francesco Angrilli, Ubaldo Occhini, René-Olivier Casasnovas, Guillaume Cartron, Liliana Devizzi, Corinne Haioun, Anna Marina Liberati, Roch Houot, Michele Merli, Giuseppe Pietrantuono, Francesca Re, Michele Spina, Francesco Landi, Franco Cavalli, Francesco Bertoni, Davide Rossi, Nicoletta Ielmini, Elena Borgo, Stefano Luminari, Emanuele Zucca, Catherine Thieblemont
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
The IELSG38 trial was conducted to investigate the effects of subcutaneous (SC) rituximab on the complete remission (CR) rate and the benefits of SC maintenance in patients with extranodal marginal zone lymphoma (MZL) who received frontline treatment
Externí odkaz:
https://doaj.org/article/ca0b0cb56ee341db9e250e5812bdbf1f
Autor:
Marilia Barreca, Noémie Lang, Chiara Tarantelli, Filippo Spriano, Paola Barraja, Francesco Bertoni
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 3, Iss 8, Pp 763-794 (2022)
Antibody-drug conjugates (ADCs) are a recent, revolutionary approach for malignancies treatment, designed to provide superior efficacy and specific targeting of tumor cells, compared to systemic cytotoxic chemotherapy. Their structure combines highly
Externí odkaz:
https://doaj.org/article/2ab29059a9fe48fda446247d32770b3e
Autor:
Celeste Rizzello, Valeria Cancila, Sabina Sangaletti, Laura Botti, Chiara Ratti, Matteo Milani, Matteo Dugo, Francesco Bertoni, Claudio Tripodo, Claudia Chiodoni, Mario P. Colombo
Publikováno v:
Molecular Cancer, Vol 21, Iss 1, Pp 1-21 (2022)
Abstract Background Autoimmune disorders, including Systemic Lupus Erythematosus (SLE), are associated with increased incidence of hematological malignancies. The matricellular protein osteopontin (OPN) has been linked to SLE pathogenesis, as SLE pat
Externí odkaz:
https://doaj.org/article/0b8d25be1e9e4e95986bac29f97a0efe
Autor:
Perrine Robin, Laura Barnabei, Stefano Marocco, Jacopo Pagnoncelli, Daniele Nicolis, Chiara Tarantelli, Agatino Christian Tavilla, Roberto Robortella, Luciano Cascione, Lucas Mayoraz, Céline M.A. Journot, Mounir Mensi, Francesco Bertoni, Igor Stefanini, Sandrine Gerber-Lemaire
Publikováno v:
Biosensors and Bioelectronics: X, Vol 13, Iss , Pp 100302- (2023)
The emergence of the coronavirus 2019 (COVID-19) arose the need for rapid, accurate and massive virus detection methods to control the spread of infectious diseases. In this work, a device, deployable in non-medical environments, has been developed f
Externí odkaz:
https://doaj.org/article/86a5a012f0024510a57ef47c40de653a
Autor:
Filippo Spriano, Giulio Sartori, Chiara Tarantelli, Marilia Barreca, Gaetanina Golino, Andrea Rinaldi, Sara Napoli, Michele Mascia, Lorenzo Scalise, Alberto J. Arribas, Luciano Cascione, Emanuele Zucca, Anastasios Stathis, Eugenio Gaudio, Francesco Bertoni
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 764-774 (2022)
Abstract Inhibitors of the Bromo‐ and Extra‐Terminal domain (BET) family proteins have strong preclinical antitumor activity in multiple tumor models, including lymphomas. Limited single‐agent activity has been reported in the clinical setting.
Externí odkaz:
https://doaj.org/article/932399c982b04d1b9c6bb6911bb32de0
Autor:
Lisa Argnani, Beatrice Casadei, Carla Pelusi, Valentina Lo Preiato, Uberto Pagotto, Francesco Bertoni, Pier Luigi Zinzani
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract Immune checkpoint inhibitors (ICIs) show efficacy in the treatment of non-Hodgkin lymphomas (NHL). However, these agents are associated with a unique group of side effects called immune-related adverse events (irAEs). We conducted an observa
Externí odkaz:
https://doaj.org/article/c4a432eb5a404a069eb0b4e8270968c9
Autor:
Lodovico Terzi di Bergamo, Francesca Guidetti, Davide Rossi, Francesco Bertoni, Luciano Cascione
Publikováno v:
GigaByte (2022)
Extraction-free HTG EdgeSeq protocols are used to profile sets of genes and measure their expression. Thus, these protocols are frequently used to characterise tumours and their microenvironments. However, although positive and control genes are prov
Externí odkaz:
https://doaj.org/article/a91ff8a9b31f4de290c3c13f5db6ff23
Autor:
Chiara Tarantelli, Eleonora Cannas, Hillarie Ekeh, Carmelo Moscatello, Eugenio Gaudio, Luciano Cascione, Sara Napoli, Cesare Rech, Andrea Testa, Chiara Maniaci, Andrea Rinaldi, Emanuele Zucca, Anastasios Stathis, Alessio Ciulli, Francesco Bertoni
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 2, Iss 6, Pp 586-601 (2021)
Aim: Bromodomain and extra-terminal domain (BET) proteins are epigenetic readers that play a fundamental role in transcription regulation. Preclinical and early clinical evidence sustain BET targeting as an anti-cancer approach. BET degraders are ch
Externí odkaz:
https://doaj.org/article/acda98a21cab4711808d202bf6f8291d